C12N 2720/10071
Demonstrated in vivo effect
C12N2720/10071 (Demonstrated in vivo effect) appears on 13 US grants and 16 published applications in this corpus.
Search patents in C12N- Granted patents
- 13
- Published applications
- 16
- Assignees
- 7
- Inventors
- 26
- Latest grant
- 31 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2014 | 0 | 2 |
| 2015 | 2 | 1 |
| 2016 | 0 | 2 |
| 2017 | 2 | 3 |
| 2018 | 1 | 1 |
| 2019 | 3 | 1 |
| 2020 | 2 | 2 |
| 2021 | 0 | 1 |
| 2022 | 1 | 1 |
| 2023 | 0 | 2 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 2 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Multivalent HVT vector vaccine31 Mar 2026US 12,589,147 B2Intervet Inc.
- Recombinant herpesvirus of turkeys (HVT) and preparation method and use thereof6 Jan 2026US 12,516,353 B2Yangzhou University
- Recombinant turkey herpesvirus vaccines and uses thereof6 Sep 2022US 11,433,130 B2The Texas A&M University System
- Recombinant turkey herpesvirus vaccines and uses thereof27 Oct 2020US 10,813,991 B2The Texas A&M University System
- Recombinant turkey herpesvirus vaccines and uses thereof21 Jan 2020US 10,537,628 B2The Texas A&M University System
- Recombinant herpesvirus of turkeys (hvt) and preparation method and use thereof11 May 2023US 2023/0147673 A1Yangzhou University
- Multivalent hvt vector vaccine2 Feb 2023US 2023/0031097 A1Intervet Inc.
- Recombinant gallid herpesvirus 3 vaccines encoding heterologous avian pathogen antigens7 Apr 2022US 2022/0105174 A1The Pirbright Institute
- Recombinant turkey herpesvirus vaccines and uses thereof1 Apr 2021US 2021/0093710 A1The Texas A&M University System
- Recombinant turkey herpesvirus vaccines and uses thereof14 May 2020US 2020/0147200 A1The Texas A&M University System
Most cited
By later US patents
- Recombinant HVT vectors expressing antigens of avian pathogens and uses thereof6US 9,114,108 B2Merial Limited · 2015
- Recombinant Marek's disease viruses and uses thereof4US 10,188,720 B2Ceva Sante Animale · 2019
- HVT-vectored ND-IBD vaccine4US 10,308,956 B2Intervet Inc. · 2019
- Recombinant turkey herpesvirus vaccines and uses thereof4US 10,813,991 B2The Texas A&M University System · 2020
- Recombinant HVT vectors expressing antigens of avian pathogens and uses thereof4US 9,555,096 B2Merial Limited · 2017